₹1,184.5
3.7 (0.3%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,173.14 | Bullish |
| 10-DMA | 1,171.82 | Bullish |
| 20-DMA | 1,118.9 | Bullish |
| 50-DMA | 1,019.66 | Bullish |
| 100-DMA | 951.05 | Bullish |
| 200-DMA | 976.35 | Bullish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 66,504 | 63,879 | 60,597 | 61,859 | 48,225 |
| Total Expenditure | 53,831 | 51,418 | 48,230 | 49,115 | 36,038 |
| Other Income | 1,339 | 744 | 673 | 623 | 872 |
| Operating Profit | 14,012 | 13,204 | 13,040 | 13,367 | 13,059 |
| Interest | 516 | 498 | 744 | 789 | 233 |
| Depreciation | 2,156 | 2,079 | 1,892 | 1,737 | 1,411 |
| Profit Before Tax | 11,340 | 10,628 | 10,404 | 10,842 | 11,415 |
| Consolidated Net Profit | 8,665 | 8,151 | 8,054 | 8,141 | 8,418 |
| Adjusted EPS | 25 | 24 | 24 | 24 | 24 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 342 | 342 | 342 | 342 | 344 |
| Total Reserves | 56,634 | 49,678 | 43,240 | 36,725 | 31,524 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 1,782 | 1,843 | 4,200 | 5,658 | 6,916 |
| Other Current Liabilities | 1,654 | 2,026 | 1,746 | 2,394 | 1,940 |
| Short Term Borrowings | 5,482 | 3,434 | 7,839 | 7,489 | 4,712 |
| Total Liabilities | 68,328 | 59,615 | 58,640 | 55,976 | 48,580 |
| Capital Work in Progress | 631 | 404 | 1,175 | 866 | 1,153 |
| Long Term Loans & Advances | 1,811 | 1,307 | 1,560 | 1,894 | 3,269 |
| Currents Investments | 626 | 2,626 | 320 | 1,272 | 3,092 |
| Short Term Loans and Advances | 1,598 | 1,584 | 1,525 | 1,616 | 1,765 |
| Total Current Assets | 41,842 | 33,264 | 31,399 | 29,781 | 24,739 |
| Total Assets | 68,328 | 59,615 | 58,640 | 55,976 | 48,580 |
| Adjusted Book Value | 167 | 146 | 128 | 108 | 93 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters